Page last updated: 2024-08-21

alpha-aminopyridine and Cardio-Cutaneous Syndrome

alpha-aminopyridine has been researched along with Cardio-Cutaneous Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbadessa, G; Chandrasekhar, V; Kontaridis, MI; Schwartz, B; Wang, J; Yu, Y	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cardio-Cutaneous Syndrome

Article	Year
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy. PloS one, 2017, Volume: 12, Issue:6 Topics: Alleles; Aminopyridines; Animals; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Humans; Imidazoles; LEOPARD Syndrome; Male; Mice; Mice, Transgenic; Mutation; Myocytes, Cardiac; Phosphoproteins; Protein Domains; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases	2017

Article

Year

In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.

PloS one, 2017, Volume: 12, Issue:6

Topics: Alleles; Aminopyridines; Animals; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Humans; Imidazoles; LEOPARD Syndrome; Male; Mice; Mice, Transgenic; Mutation; Myocytes, Cardiac; Phosphoproteins; Protein Domains; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2017